04/15/2014 - 11:19am

Merck announced that the Food and Drug Administration has approved Grastek (Timothy grass pollen allergen extract) tablet for sublingual use.

04/15/2014 - 11:18am

Quest Products on Friday announced the addition of a gel formulated for emergency burn relief, Alocane Emergency Burn Gel, to its current line of products.

04/15/2014 - 10:43am

Mylan announced that it has launched eszopiclone tablets in 1 mg, 2 mg and 3 mg form.

04/15/2014 - 10:15am

Greenstone, a generic pharmaceutical subsidiary of Pfizer, announced the introduction of amlodipine besylate/atorvastatin calcium tablets to its roster of products.

04/14/2014 - 10:35am

AssistRx last week introduced a new technology that simplifies the prescribing of specialty therapies while streamlining communications between prescribers, pharmacies, patients and manufacturers. It’s smart technology that can lead to patients receiving specialty medications weeks earlier than ever before, the company claimed.

04/10/2014 - 2:39pm

Lupin announced that it received final approval from the Food and Drug Administration for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths.

04/09/2014 - 11:11am

GM Pharmaceuticals recently announced the addition of 8-oz. bottles to its line of liquid pain relief VanaPain.

04/09/2014 - 9:37am

Herb Pharm recently debuted a new logo and label design across its entire product line in conjunction with the launch of three new herbal supplements — Inflamma Response capsules, Passionflower capsules and Turmeric softgels.

04/08/2014 - 10:46am

Teva Pharmaceutical Industries announced that it has received approval from the Food and Drug Administration for its generic form of Lovaza (omega-3-acid ethyl esters capsules, USP) in the United States.